Neuro-Immunity and Gut Dysbiosis Drive Parkinson's Disease-Induced Pain.

Parkinson’s disease dysbiosis gut-brain axis microbiota neuro-immunity nociceptor neurons pain

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 16 08 2021
accepted: 21 10 2021
entrez: 6 12 2021
pubmed: 7 12 2021
medline: 9 2 2022
Statut: epublish

Résumé

Parkinson's disease (PD) is the second most common neurodegenerative disorder, affecting 1-2% of the population aged 65 and over. Additionally, non-motor symptoms such as pain and gastrointestinal dysregulation are also common in PD. These impairments might stem from a dysregulation within the gut-brain axis that alters immunity and the inflammatory state and subsequently drives neurodegeneration. There is increasing evidence linking gut dysbiosis to the severity of PD's motor symptoms as well as to somatosensory hypersensitivities. Altogether, these interdependent features highlight the urgency of reviewing the links between the onset of PD's non-motor symptoms and gut immunity and whether such interplays drive the progression of PD. This review will shed light on maladaptive neuro-immune crosstalk in the context of gut dysbiosis and will posit that such deleterious interplays lead to PD-induced pain hypersensitivity.

Identifiants

pubmed: 34868000
doi: 10.3389/fimmu.2021.759679
pmc: PMC8637106
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

759679

Subventions

Organisme : CIHR
ID : 162211
Pays : Canada
Organisme : CIHR
ID : 461274
Pays : Canada
Organisme : CIHR
ID : 461275
Pays : Canada

Informations de copyright

Copyright © 2021 Roversi, Callai-Silva, Roversi, Griffith, Boutopoulos, Prediger and Talbot.

Déclaration de conflit d'intérêts

ST has an equity stake in Nocion Therapeutics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Neurosci Lett. 1991 Oct 28;132(1):105-8
pubmed: 1724065
Mov Disord. 2012 May;27(6):709-15
pubmed: 21766334
Neuroscience. 2015 Apr 2;290:126-37
pubmed: 25637492
Trends Immunol. 2018 Mar;39(3):240-255
pubmed: 29338939
Arch Neurol. 2008 Sep;65(9):1191-4
pubmed: 18779422
Exp Neurol. 2006 Aug;200(2):480-5
pubmed: 16674943
Nat Commun. 2018 Jan 2;9(1):37
pubmed: 29295977
Cell. 2016 Jun 30;166(1):209-21
pubmed: 27238020
J Neurol. 2013 May;260(5):1332-8
pubmed: 23263478
Rev Neurol. 2011 Apr 1;52(7):385-93
pubmed: 21425107
Ann Rheum Dis. 2016 Apr;75(4):730-8
pubmed: 26613766
J Pain. 2009 Sep;10(9):895-926
pubmed: 19712899
Brain Behav Immun. 2018 May;70:48-60
pubmed: 29471030
Front Immunol. 2017 Sep 26;8:1166
pubmed: 29018440
Annu Rev Neurosci. 1981;4:227-72
pubmed: 6111979
Neurosci Lett. 1996 Jun 14;211(1):13-6
pubmed: 8809836
Science. 1988 Sep 2;241(4870):1218-21
pubmed: 2457950
Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11330-5
pubmed: 19564617
Ann Oncol. 2012 Sep;23 Suppl 10:x294-301
pubmed: 22987980
Neurology. 2001 Aug 14;57(3):456-62
pubmed: 11502913
J Comp Neurol. 1995 Jan 23;351(4):568-84
pubmed: 7721984
Mov Disord. 2005 Dec;20(12):1557-63
pubmed: 16078219
Pain. 2016 Jun;157(6):1192-1193
pubmed: 27183444
J Mov Disord. 2014 Apr;7(1):7-12
pubmed: 24926404
Curr Opin Investig Drugs. 2008 Jul;9(7):726-34
pubmed: 18600578
J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):24-8
pubmed: 18653553
Immunity. 2015 Sep 15;43(3):515-26
pubmed: 26377898
Endocrine. 2012 Aug;42(1):118-24
pubmed: 22371119
EMBO J. 2005 Dec 21;24(24):4211-23
pubmed: 16319926
Science. 2016 Sep 30;353(6307):
pubmed: 27708076
J Biol Chem. 1990 Jul 5;265(19):10805-8
pubmed: 1694171
Parkinsonism Relat Disord. 2018 Jul;52:83-89
pubmed: 29625875
Anesthesiology. 2018 Aug;129(2):343-366
pubmed: 29462012
Parkinsonism Relat Disord. 2013 May;19(5):548-52
pubmed: 23462484
Nature. 2021 Mar;591(7849):275-280
pubmed: 33442058
Eur J Neurol. 2018 Jul;25(7):917-e69
pubmed: 29520899
Mol Med Rep. 2018 Jun;17(6):7567-7574
pubmed: 29620246
J Neuroimmunol. 2012 Nov 15;252(1-2):95-9
pubmed: 22910543
Nat Rev Neurol. 2012 Apr 17;8(5):284-94
pubmed: 22508236
Parkinsonism Relat Disord. 2019 Sep;66:74-79
pubmed: 31320275
N Engl J Med. 1996 Apr 25;334(17):1106-15
pubmed: 8598871
Medicine (Baltimore). 2019 Jun;98(26):e16163
pubmed: 31261545
Brain. 2016 May;139(Pt 5):1361-77
pubmed: 26984186
Science. 2013 Aug 2;341(6145):569-73
pubmed: 23828891
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6
pubmed: 18936492
J Neurosci. 2009 Nov 18;29(46):14415-22
pubmed: 19923276
Neurosci Lett. 2006 Mar 20;396(1):67-72
pubmed: 16330147
ACS Chem Neurosci. 2019 May 15;10(5):2229-2236
pubmed: 30855940
Neuron. 2018 Feb 21;97(4):806-822.e10
pubmed: 29429934
Acta Neuropathol. 2014 Dec;128(6):805-20
pubmed: 25296989
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1755-60
pubmed: 15665080
Brain Res. 2010 Oct 8;1355:195-206
pubmed: 20691673
Neurology. 2016 Nov 1;87(18):1892-1898
pubmed: 27683845
Blood. 2008 Sep 1;112(5):1557-69
pubmed: 18725574
Parkinsonism Relat Disord. 2018 Nov;56:27-32
pubmed: 29903584
Neurobiol Dis. 2015 Oct;82:185-199
pubmed: 26093169
Mov Disord. 2017 Aug;32(8):1256-1258
pubmed: 28582598
J Pain Symptom Manage. 2006 Nov;32(5):462-9
pubmed: 17085272
J Neuroimmunol. 2010 Dec 15;229(1-2):26-50
pubmed: 20870295
Pain. 2015 Mar;156(3):415-427
pubmed: 25599239
Nature. 2013 Dec 19;504(7480):451-5
pubmed: 24226773
Front Cell Infect Microbiol. 2020 Mar 24;10:98
pubmed: 32266160
Neurosci Bull. 2012 Apr;28(2):131-44
pubmed: 22466124
Brain Behav Immun. 2009 Jan;23(1):55-63
pubmed: 18678243
Brain. 2008 Jul;131(Pt 7):1903-11
pubmed: 18515869
Parkinsonism Relat Disord. 2015 Apr;21(4):361-5
pubmed: 25630889
Diabetologia. 2005 May;48(5):805-7
pubmed: 15834549
Neurobiol Dis. 2013 Feb;50:42-8
pubmed: 23017648
Neurobiol Dis. 2018 Apr;112:106-118
pubmed: 29341898
Nat Commun. 2014 Apr 16;5:3633
pubmed: 24736453
Cell Calcium. 2018 Jul;73:72-81
pubmed: 29689522
Neuropsychiatr Dis Treat. 2012;8:435-42
pubmed: 23091387
Cell. 2009 Oct 16;139(2):267-84
pubmed: 19837031
J Neuroimmunol. 2001 Feb 1;113(1):146-52
pubmed: 11137586
Nature. 2017 Jan 12;541(7636):176-181
pubmed: 28002412
Int J Clin Exp Pathol. 2015 Mar 01;8(3):2495-504
pubmed: 26045755
Eur J Neurol. 2013 Oct;20(10):1398-404
pubmed: 23679105
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20602-7
pubmed: 23185004
Lancet Neurol. 2015 Jan;14(1):57-64
pubmed: 25435387
Neurosci Lett. 2017 May 1;648:21-25
pubmed: 28359932
Mov Disord. 2016 Dec;31(12):1854-1864
pubmed: 27704616
Neurology. 2017 Aug 22;89(8):776-784
pubmed: 28747449
J Immunol. 2011 Jun 1;186(11):6417-26
pubmed: 21515789
Annu Rev Immunol. 2016 May 20;34:421-47
pubmed: 26907213
Nature. 1997 Oct 23;389(6653):816-24
pubmed: 9349813
J Neuroimmune Pharmacol. 2012 Dec;7(4):927-38
pubmed: 23054369
Science. 2018 Sep 21;361(6408):
pubmed: 30237325
Cell. 2017 Mar 9;168(6):1135-1148.e12
pubmed: 28262351
J Biomed Sci. 2018 Oct 11;25(1):73
pubmed: 30309367
Auton Neurosci. 2011 Apr 26;161(1-2):1-5
pubmed: 21147045
Nature. 2017 Jun 29;546(7660):656-661
pubmed: 28636593
Neurobiol Dis. 2009 Oct;36(1):96-102
pubmed: 19595768
Pain. 1999 Aug;Suppl 6:S121-S126
pubmed: 10491980
J Gastroenterol Hepatol. 2019 Aug;34(8):1368-1376
pubmed: 30402954
Neurology. 2013 Oct 29;81(18):1604-10
pubmed: 24089386
Nat Neurosci. 2015 Jul;18(7):965-77
pubmed: 26030851
Behav Pharmacol. 2018 Apr;29(2 and 3-Spec Issue):103-119
pubmed: 29521671
Cell. 2016 Dec 1;167(6):1469-1480.e12
pubmed: 27912057
Nat Med. 2015 May;21(5):518-23
pubmed: 25915831
Acta Neuropathol. 2014 Nov;128(5):651-63
pubmed: 25284487
Dis Mon. 2016 Sep;62(9):324-9
pubmed: 27329514
Medicine (Baltimore). 2020 Aug 28;99(35):e22035
pubmed: 32871960
Nat Commun. 2014;5:3125
pubmed: 24445575
Parkinsonism Relat Disord. 2010 Feb;16(2):79-84
pubmed: 19846332
Int J Neural Syst. 1996 Sep;7(4):507-17
pubmed: 8968842
PLoS One. 2013 May 02;8(5):e63564
pubmed: 23658840
J Neurol Sci. 2017 Jul 15;378:204-209
pubmed: 28566165
Mol Pain. 2021 Jan-Dec;17:1744806921996520
pubmed: 33626986
Pain. 2017 Nov;158(11):2243-2258
pubmed: 28837503
Pain Med. 2016 Mar;17(3):456-462
pubmed: 26352288
Arthritis Rheum. 2010 Dec;62(12):3806-14
pubmed: 20722011
Nature. 2001 Sep 13;413(6852):203-10
pubmed: 11557989
Neurology. 2007 Dec 4;69(23):2162-9
pubmed: 18056580
Arthritis Rheum. 2012 Dec;64(12):3897-907
pubmed: 22933159
J Parkinsons Dis. 2019;9(4):761-765
pubmed: 31381529
Front Endocrinol (Lausanne). 2020 Sep 02;11:605
pubmed: 32982987
Neurobiol Dis. 2010 Apr;38(1):1-7
pubmed: 20044003
J Neurol Sci. 2018 Sep 15;392:3-7
pubmed: 30097149
Cell. 2020 Jan 9;180(1):33-49.e22
pubmed: 31813624
Cell Mol Gastroenterol Hepatol. 2019;7(2):433-445
pubmed: 30739868
Mol Pain. 2011 Sep 28;7:74
pubmed: 21951975
J Neuroinflammation. 2018 Jul 12;15(1):205
pubmed: 30001736
Nature. 2019 Feb;566(7745):503-508
pubmed: 30787438
Pain. 2009 Jan;141(1-2):173-7
pubmed: 19100686
Ann Neurol. 2015 Oct;78(4):522-9
pubmed: 26031848
J Neuroimmunol. 2007 Aug;188(1-2):117-27
pubmed: 17582512
J Gastroenterol Hepatol. 2018 Oct;33(10):1751-1760
pubmed: 29532517
J Neurol Sci. 2011 Nov 15;310(1-2):12-6
pubmed: 21621226
Cell. 2017 Jun 29;170(1):185-198.e16
pubmed: 28648659
Mov Disord. 2015 Feb;30(2):229-37
pubmed: 25449044
J Formos Med Assoc. 2014 Dec;113(12):921-8
pubmed: 23870713
EBioMedicine. 2019 Aug;46:499-511
pubmed: 31327695
J Neuroinflammation. 2019 Jun 27;16(1):129
pubmed: 31248424
Clin Neuropharmacol. 2007 Jul-Aug;30(4):201-5
pubmed: 17762316
J Pain Relief. 2014 Jun;Suppl 3:003
pubmed: 25143871
Mol Med Rep. 2015 Oct;12(4):6105-11
pubmed: 26239429
Nat Commun. 2016 Jun 28;7:12029
pubmed: 27349690
Front Immunol. 2017 Nov 03;8:1463
pubmed: 29163530
Inflamm Bowel Dis. 2014 Mar;20(3):417-30
pubmed: 24418903
Br J Pharmacol. 1995 Aug;115(7):1265-75
pubmed: 7582555
Sci Transl Med. 2018 Jan 10;10(423):
pubmed: 29321258
Neurosci Lett. 1995 Dec 29;202(1-2):17-20
pubmed: 8787820
NeuroRx. 2005 Oct;2(4):650-61
pubmed: 16489372
Microb Cell Fact. 2021 May 13;20(1):98
pubmed: 33985520
J Pain. 2014 May;15(5):496-506
pubmed: 24793056
Acta Neuropathol. 2007 Apr;113(4):421-9
pubmed: 17294202
Am J Physiol Cell Physiol. 2008 Jun;294(6):C1586-96
pubmed: 18434625
Pain. 2005 Aug;116(3):257-263
pubmed: 15964142
Nature. 1988 Aug 25;334(6184):698-700
pubmed: 3137474
Neurobiol Dis. 2012 Aug;47(2):258-67
pubmed: 22549133
Curr Neuropharmacol. 2013 Dec;11(6):592-7
pubmed: 24396335
Mol Pain. 2005 Jan 17;1:3
pubmed: 15813989
Mov Disord. 2020 Sep;35(9):1626-1635
pubmed: 32557853
Annu Rev Physiol. 1999;61:117-42
pubmed: 10099684
Pain. 2019 Dec;160(12):2855-2865
pubmed: 31343542
J Dent Res. 2011 Jun;90(6):759-64
pubmed: 21393555
Mov Disord. 2014 Jul;29(8):999-1009
pubmed: 24898698
Nature. 2019 Jul;571(7766):565-569
pubmed: 31316206
Ann Clin Transl Neurol. 2014 Jul;1(7):471-8
pubmed: 25356418
Neuroreport. 2001 Oct 8;12(14):3077-80
pubmed: 11568640
Nature. 2013 Dec 19;504(7480):446-50
pubmed: 24226770
Mov Disord. 2008 Jul 30;23(10):1361-9
pubmed: 18546344
Nat Rev Drug Discov. 2014 Jul;13(7):533-48
pubmed: 24948120
Trends Neurosci. 2020 Oct;43(10):822-838
pubmed: 32839001
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt B):200-206
pubmed: 29031913
Cell Stem Cell. 2018 Jul 05;23(1):123-131.e6
pubmed: 29979986
Mov Disord. 2010 Aug 15;25(11):1646-51
pubmed: 20629164
J Physiol. 1999 Apr 15;516 ( Pt 2):433-46
pubmed: 10087343
Mov Disord. 2012 Apr;27(4):485-91
pubmed: 21953990
Mov Disord. 2016 Jul;31(7):995-1003
pubmed: 26999434
JAMA Neurol. 2016 Nov 1;73(11):1316-1324
pubmed: 27668667
Acta Neuropathol Commun. 2021 Feb 25;9(1):31
pubmed: 33632316
Nutrients. 2011 Oct;3(10):858-76
pubmed: 22254083
Nat Neurosci. 2017 Jul;20(7):917-926
pubmed: 28530662

Auteurs

Katiane Roversi (K)

Département de Pharmacologie et Physiologie, Université de Montréal, Montréal, QC, Canada.
Centre de Recherche Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
Département d'Ophtalmologie, Université de Montréal, Montréal, QC, Canada.
Departamento de Farmacologia, Universidade Federal de Santa Catarina, Florianópolis, Brazil.

Natalia Callai-Silva (N)

Département de Pharmacologie et Physiologie, Université de Montréal, Montréal, QC, Canada.
Centre de Recherche Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
Département d'Ophtalmologie, Université de Montréal, Montréal, QC, Canada.

Karine Roversi (K)

Département de Pharmacologie et Physiologie, Université de Montréal, Montréal, QC, Canada.

May Griffith (M)

Centre de Recherche Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
Département d'Ophtalmologie, Université de Montréal, Montréal, QC, Canada.

Christos Boutopoulos (C)

Centre de Recherche Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
Département d'Ophtalmologie, Université de Montréal, Montréal, QC, Canada.

Rui Daniel Prediger (RD)

Departamento de Farmacologia, Universidade Federal de Santa Catarina, Florianópolis, Brazil.

Sébastien Talbot (S)

Département de Pharmacologie et Physiologie, Université de Montréal, Montréal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH